Amphastar Pharmaceuticals (DE:29A)
FRANKFURT:29A
Holding DE:29A?
Track your performance easily

Amphastar Pharmaceuticals (29A) Balance Sheet

0 Followers

Amphastar Pharmaceuticals Balance Sheet

Amphastar Pharmaceuticals's total assets for Q3 2024 were $1.55B, an increase of 3.60% from the previous quarter. DE:29A total liabilities were $817.50M for the fiscal quarter, a 5.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.51B$ 741.99M$ 671.49M$ 631.27M$ 586.97M
Total Liabilities
$ 873.49M$ 213.33M$ 226.01M$ 182.51M$ 159.44M
Total Equity Gross Minority
$ 639.42M$ 528.66M$ 445.52M$ 448.72M$ 427.53M
Total Capitalization
$ 1.85B$ 698.03M$ 619.78M$ 488.14M$ 420.76M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Amphastar Pharmaceuticals Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis